Pharma BD Deal Intelligence
Pfizer, which had announced plans to divest nutrition and animal health, signaled it would retain and bulk up the consumer health unit by acquiring Alacer…
We expect that our global network and deep expertise in dietary supplements combined with our desire to provide consumers with high-quality products will make…
Pfizer acquires Emergen-C maker; companies said it will help expand Emergen-C distribution. Emergen-C products add to and greatly complement Pfizer's…
Source summaries from our enrichment pipeline; follow links for originals.
All 6 sources with sentiment breakdown →
Pfizer Consumer Healthcare acquired Alacer Corp. (Emergen-C). Note: borderline consumer health rather than pharma; included for completeness given Pfizer's broader 2011 consumer-health roll-up.
Assessment window: 5yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Pfizer Inc. / Alacer Corp. (this deal) | 2011 | — | 61 |
| Pfizer Inc. / BioNTech SE | 2020 | $748M | 100 |
| Pfizer Inc. / FoldRx Pharmaceuticals | 2010 | — | 99 |
| Pfizer Inc. / Medivation Inc. | 2016 | $14.0B | 86 |
| Pfizer Inc. / Wyeth | 2009 | $68.0B | 86 |
| Pfizer Inc. / Warner-Lambert Company | 2000 | $90.0B | 83 |
| Pfizer Inc. / Arvinas, Inc. | 2021 | $2.4B | 77 |
← Browse all deals · How we score deals
More: 2011 deals · Pfizer Inc. deals · Other deals